Get the Stockscreener App
2.14
87.72%
1.00
After Hours:
2.62
0.48
+22.43%
Microbot Medical Inc stock is traded at $2.14, with a volume of 22.68M.
It is up +87.72% in the last 24 hours and up +111.88% over the past month.
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
See More
Previous Close:
$1.14
Open:
$1.18
24h Volume:
22.68M
Relative Volume:
34.09
Market Cap:
$36.24M
Revenue:
-
Net Income/Loss:
$-10.58M
P/E Ratio:
-1.7833
EPS:
-1.2
Net Cash Flow:
$-9.21M
1W Performance:
+92.79%
1M Performance:
+111.88%
6M Performance:
+103.81%
1Y Performance:
+53.96%
1-Day Range:
$1.15
$2.25
1-Week Range:
$1.08
$2.25
52-Week Range:
$0.82
$2.3499
Microbot Medical Inc Stock (MBOT) Company Profile
Name
Microbot Medical Inc
Sector
Industry
Phone
908-938-5561
Address
25 RECREATION PARK DR SUITE 108, HINGHAM, MA
Compare MBOT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MBOT
Microbot Medical Inc
|
2.14 | 36.24M | 0 | -10.58M | -9.21M | -1.20 |
|
ISRG
Intuitive Surgical Inc
|
535.29 | 190.66B | 7.87B | 2.24B | 586.00M | 6.22 |
|
BDX
Becton Dickinson Co
|
228.46 | 66.26B | 20.18B | 1.71B | 3.07B | 5.94 |
|
ALC
Alcon Inc
|
84.06 | 41.58B | 9.76B | 1.16B | 665.00M | 2.34 |
|
RMD
Resmed Inc
|
231.67 | 34.01B | 4.81B | 1.11B | 1.35B | 7.55 |
|
WST
West Pharmaceutical Services Inc
|
335.56 | 24.30B | 2.88B | 499.60M | 321.60M | 6.74 |
Microbot Medical Inc Stock (MBOT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-20 | Reiterated | H.C. Wainwright | Buy |
| Dec-24-19 | Reiterated | H.C. Wainwright | Buy |
| Jan-31-18 | Initiated | Ladenburg Thalmann | Buy |
Microbot Medical Inc Stock (MBOT) Latest News
Another Robotics Stock on the Move; Microbot Medical Inc. (Nasdaq: MBOT) - Investorideas.com newswire
Symbol Lookup - GuruFocus.com
Comparing Inspire Medical Systems (NYSE:INSP) and Microbot Medical (NASDAQ:MBOT) - Defense World
Microbot Medical anticipates launch of LIBERTY in Q2 in the U.S. - TipRanks
Microbot Medical Advances with LIBERTY System Milestones - TipRanks
Microbot Medical® Concludes 2024 by Achieving Key Milestones Culminating in FDA Submission for the Commercialization of LIBERTY® - The Manila Times
Microbot Medical® Concludes 2024 by Achieving Key - GlobeNewswire
Microbot Medical Submits FDA 510(k) for Revolutionary LIBERTY Endovascular Robotic System, Eyes Q2 2025 Launch - StockTitan
Microbot Medical (NASDAQ:MBOT) Stock Price Passes Above Two Hundred Day Moving Average – Here’s Why - Defense World
MBOT Stock Gains Following FDA Submission of the LIBERTY System - MSN
Microbot Medical appoints new director and committee member By Investing.com - Investing.com Australia
Microbot Medical appoints new director and committee member - Investing.com
Microbot Medical Stockholders Approve Key Proposals in 2024 - TipRanks
Palm-Sized Innovation: How Microbot Medical Is Helping Redefine Surgical Robotics - Nasdaq
Advanced Robotics Are Reshaping Medicine - Nasdaq
Revolutionary Robotic Surgery System Set for FDA Review! Is the Future Here? - Robots Rising
Microbot Medical submits LIBERTY surgical robot to FDA for approval - Robot Report
Microbot Medical Submits FDA 510(k) Premarket Notification for LIBERTY ® Endovascular Robotic System - Defense World
Microbot Medical Inc. Announces FDA Submission for the Commercialization of the LIBERTY Endovascular Robotic System - Marketscreener.com
Microbot Medical seeks FDA clearance for endovascular robotic system - Yahoo! Voices
Microbot Medical announces US FDA submission for commercialisation of Liberty endovascular robotic system - Vascular News
Microbot Medical Submits 510(k) for Liberty Surgical Robot to FDA - MPO-mag
Microbot Medical® CEO Harel Gadot to Discuss Endovascular Robotics on Benzinga All Access - The Bakersfield Californian
Microbot Medical's Revolutionary Disposable Robotic Surgery System Awaits FDA Decision - StockTitan
Microbot Medical Advances with LIBERTY® FDA Submission - TipRanks
Microbot Medical® Announces FDA Submission for the Commercialization of the LIBERTY® Endovascular Robotic System - The Manila Times
Microbot Medical® Announces FDA Submission for the - GlobeNewswire
Microbot Medical Files FDA Application for Revolutionary Disposable Robotic Surgery System - StockTitan
Microbot Medical (STU:CY9D) EV-to-Revenue : (As of Dec. 05, 2024) - GuruFocus.com
MBOT (Microbot Medical) EPS without NRI : $-0.80 (TTM As of Sep. 2024) - GuruFocus.com
Microbot Medical Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Microbot Medical (MBOT) Stock Price, News & Analysis - MarketBeat
Microbot Medical’s Liberty Robot Study Draws to a Close - MPO-mag
Microbot Medical Releases Investor Presentation Materials - TipRanks
Yoav Zvi Waizer Net Worth (2024) - GuruFocus.com
Microbot Medical LIBERTY System Trial Advancing Faster Than Expected - MPO-mag
Microbot Medical Announces the Successful Completion of its Pivotal Human Clinical Trial; Accelerates Go-to-Market Strategy to Prepare for Commercial Launch of LIBERTY® during 2Q 2025 - MSN
Microbot Medical Stock Rises After Completing ACCESS-PVI Trial - Yahoo Finance
Market Update: Microbot Medical Inc (MBOT) Sees Positive Movement, Closing at 0.96 - The Dwinnex
Microbot Medical completes key clinical trial, eyes FDA submission By Investing.com - Investing.com Australia
CMR Surgical wins FDA nod for surgical robot Versius - Medical Device Network
Microbot eyes FDA application for surgical robot after completing pivotal trial - Medical Device Network
Microbot Medical completes enrolment for ACCESS-PVI clinical trial - Vascular News
Microbot Medical completes key clinical trial, eyes FDA submission - Investing.com
Microbot Medical Advances Towards FDA Submission and Market Entry - TipRanks
Microbot Medical Announces the Successful Completion of its - GlobeNewswire
Microbot Medical faces Nasdaq delisting over share price - Investing.com India
Microbot Medical faces Nasdaq delisting over share price By Investing.com - Investing.com South Africa
Microbot Medical nears end of pivotal clinical trial - Investing.com
Microbot shifts pivotal trial up a gear with completion expected ahead of schedule - Medical Device Network
Microbot Medical Nears FDA Submission with Clinical Advances - TipRanks
Microbot Medical Inc Stock (MBOT) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
0.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):